CGEN

$0.00

(

0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Compugen

NASDAQ | CGEN

2.11

USD

$0.00

(

0.00%

)

At Close (As of Oct 14, 2025)

$209.52M

Market Cap

-

P/E Ratio

-0.22

EPS

$2.66

52 Week High

$1.12

52 Week Low

HEALTHCARE

Sector

CGEN Chart

Recent Chart
Price Action

CGEN Technicals

Tags:

CGEN Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $20M
Total Revenue $28M
Cost Of Revenue $7.9M
Costof Goods And Services Sold $7.9M
Operating Income -$15M
Selling General And Administrative $9.4M
Research And Development $25M
Operating Expenses $35M
Investment Income Net -
Net Interest Income $5.2M
Interest Income $3.5M
Interest Expense $34K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $486K
Income Before Tax -$9.7M
Income Tax Expense $4.5M
Interest And Debt Expense -
Net Income From Continuing Operations -$14M
Comprehensive Income Net Of Tax -
Ebit -$15M
Ebitda -$14M
Net Income -$14M

Revenue & Profitability

Earnings Performance

CGEN Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $115M
Total Current Assets $106M
Cash And Cash Equivalents At Carrying Value $18M
Cash And Short Term Investments $18M
Inventory -
Current Net Receivables $269K
Total Non Current Assets $9M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments -
Short Term Investments $85M
Other Current Assets $2.5M
Other Non Current Assets -
Total Liabilities $60M
Total Current Liabilities $20M
Current Accounts Payable $1.8M
Deferred Revenue -
Current Debt -
Short Term Debt $448K
Total Non Current Liabilities $40M
Capital Lease Obligations $2.9M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $2.9M
Other Current Liabilities $8.2M
Other Non Current Liabilities -
Total Shareholder Equity $55M
Treasury Stock -
Retained Earnings -$489M
Common Stock $248K
Common Stock Shares Outstanding $90M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow $50M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $486K
Capital Expenditures $118K
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -$46M
Cashflow From Financing $554K
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$14M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $20M
Total Revenue $28M
Cost Of Revenue $7.9M
Costof Goods And Services Sold $7.9M
Operating Income -$15M
Selling General And Administrative $9.4M
Research And Development $25M
Operating Expenses $35M
Investment Income Net -
Net Interest Income $5.2M
Interest Income $3.5M
Interest Expense $34K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $486K
Income Before Tax -$9.7M
Income Tax Expense $4.5M
Interest And Debt Expense -
Net Income From Continuing Operations -$14M
Comprehensive Income Net Of Tax -
Ebit -$15M
Ebitda -$14M
Net Income -$14M

CGEN News

CGEN Profile

Compugen Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Compugen Ltd. (CGEN) is a clinical-stage biotechnology company focused on the discovery and development of novel therapeutics for cancer and autoimmune diseases. With a robust pipeline of immuno-oncology candidates, the company leverages its proprietary computational discovery platform to identify and advance unique therapeutic targets. Headquartered in Holon, Israel, Compugen is strategically positioned to engage with global markets, particularly in the United States and Europe, as it pursues its mission to enhance treatment options in oncology and beyond.

VHAI
0.00%
$0.00
YYAI
-11.76%
$0.15
BURU
-19.92%
$0.41
UGRO
+54.52%
$0.57
BITF
+9.27%
$5.89
NVDA
-4.40%
$180.03
PLUG
+3.84%
$4.05
CGBS
-39.47%
$0.03
NVTS
+26.07%
$12.57
TMQ
+61.58%
$10.60
RGTI
+2.20%
$56.12
CAN
+18.42%
$1.80
DNN
+3.57%
$3.19
LAES
+24.79%
$7.65
INTC
-4.27%
$35.63
BYND
-24.56%
$0.78
JOBY
+7.99%
$18.11
RR
+4.34%
$6.73
RXRX
+6.50%
$5.89
SSKN
+41.55%
$2.18
ITP
+31.01%
$0.34
F
+0.95%
$11.65
EDHL
+114.42%
$1.07
COOT
+46.21%
$0.96
CRML
+28.73%
$29.97
DVLT
+28.82%
$2.19
NAK
+3.75%
$2.76
SOUN
+8.98%
$20.86
ACHR
+1.95%
$13.02
WULF
+10.42%
$15.46
BBD
+1.94%
$3.15
TLRY
-5.32%
$1.60
SOFI
+2.68%
$27.87
GPUS
-5.58%
$0.40
IONZ
+11.73%
$2.57
BTBT
+3.25%
$4.13
QBTS
+6.00%
$43.06
TSLA
-1.52%
$429.24
MARA
+9.88%
$22.24
AMD
+0.77%
$218.09
MNTS
+19.58%
$1.71
AXDX
-61.36%
$0.03
CLF
+0.94%
$13.96
AAL
+3.83%
$12.19
ERIC
+20.56%
$9.85
RIG
-2.50%
$3.12
ETHD
+6.60%
$3.55
UUUU
+10.34%
$26.23
CIFR
+2.70%
$20.89
NIO
-5.29%
$6.80
NEHC
+30.63%
$3.07
NUAI
+30.63%
$3.07
QUBT
+1.49%
$21.78
UAMY
+4.54%
$17.47
IREN
+8.45%
$69.56
ASST
-7.69%
$0.99
CLSK
+9.68%
$21.98
NOK
+4.19%
$5.47
GNPX
+30.15%
$0.25
BTG
+0.56%
$5.34
PLTR
+1.42%
$179.74
APLD
+2.33%
$35.04
AREC
+36.74%
$6.81
ADAP
-11.16%
$0.16
AMZN
-1.67%
$216.39
RF
+2.44%
$25.16
WWR
+35.93%
$3.48
USAR
-2.93%
$37.54
JDZG
+59.57%
$3.00
ABAT
+22.88%
$11.33
T
+2.11%
$26.13
BAC
+2.51%
$50.09
PFE
-0.84%
$24.52
QS
-0.64%
$16.88
BMNR
-6.91%
$52.92
SNAP
-1.61%
$7.92
MP
+3.77%
$98.65
RMBL
+60.50%
$3.21
ADD
-25.47%
$0.05
BCRX
-8.80%
$6.42
JBLU
+7.91%
$4.91
WFC
+7.14%
$84.56
ONDS
-3.70%
$10.41
AAPL
+0.04%
$247.77
SRM
+53.27%
$10.30
ATXS
+37.07%
$11.61
HPE
+0.80%
$25.00
IONQ
-5.53%
$77.55
AQMS
+198.89%
$29.62
EOSE
-0.41%
$16.98
NAKA
-7.78%
$0.78
KDLY
-7.78%
$0.78
VALE
-0.36%
$10.97
C
+3.89%
$99.84
RGTZ
-5.37%
$8.80
GRAB
-0.33%
$5.91
HOOD
-4.07%
$134.94
BULL
-0.08%
$11.73
WMT
+4.98%
$107.21
GWH
-16.24%
$7.58
VHAI
0.00%
$0.00
YYAI
-11.76%
$0.15
BURU
-19.92%
$0.41
UGRO
+54.52%
$0.57
BITF
+9.27%
$5.89
NVDA
-4.40%
$180.03
PLUG
+3.84%
$4.05
CGBS
-39.47%
$0.03
NVTS
+26.07%
$12.57
TMQ
+61.58%
$10.60
RGTI
+2.20%
$56.12
CAN
+18.42%
$1.80
DNN
+3.57%
$3.19
LAES
+24.79%
$7.65
INTC
-4.27%
$35.63
BYND
-24.56%
$0.78
JOBY
+7.99%
$18.11
RR
+4.34%
$6.73
RXRX
+6.50%
$5.89
SSKN
+41.55%
$2.18
ITP
+31.01%
$0.34
F
+0.95%
$11.65
EDHL
+114.42%
$1.07
COOT
+46.21%
$0.96
CRML
+28.73%
$29.97
DVLT
+28.82%
$2.19
NAK
+3.75%
$2.76
SOUN
+8.98%
$20.86
ACHR
+1.95%
$13.02
WULF
+10.42%
$15.46
BBD
+1.94%
$3.15
TLRY
-5.32%
$1.60
SOFI
+2.68%
$27.87
GPUS
-5.58%
$0.40
IONZ
+11.73%
$2.57
BTBT
+3.25%
$4.13
QBTS
+6.00%
$43.06
TSLA
-1.52%
$429.24
MARA
+9.88%
$22.24
AMD
+0.77%
$218.09
MNTS
+19.58%
$1.71
AXDX
-61.36%
$0.03
CLF
+0.94%
$13.96
AAL
+3.83%
$12.19
ERIC
+20.56%
$9.85
RIG
-2.50%
$3.12
ETHD
+6.60%
$3.55
UUUU
+10.34%
$26.23
CIFR
+2.70%
$20.89
NIO
-5.29%
$6.80
NEHC
+30.63%
$3.07
NUAI
+30.63%
$3.07
QUBT
+1.49%
$21.78
UAMY
+4.54%
$17.47
IREN
+8.45%
$69.56
ASST
-7.69%
$0.99
CLSK
+9.68%
$21.98
NOK
+4.19%
$5.47
GNPX
+30.15%
$0.25
BTG
+0.56%
$5.34
PLTR
+1.42%
$179.74
APLD
+2.33%
$35.04
AREC
+36.74%
$6.81
ADAP
-11.16%
$0.16
AMZN
-1.67%
$216.39
RF
+2.44%
$25.16
WWR
+35.93%
$3.48
USAR
-2.93%
$37.54
JDZG
+59.57%
$3.00
ABAT
+22.88%
$11.33
T
+2.11%
$26.13
BAC
+2.51%
$50.09
PFE
-0.84%
$24.52
QS
-0.64%
$16.88
BMNR
-6.91%
$52.92
SNAP
-1.61%
$7.92
MP
+3.77%
$98.65
RMBL
+60.50%
$3.21
ADD
-25.47%
$0.05
BCRX
-8.80%
$6.42
JBLU
+7.91%
$4.91
WFC
+7.14%
$84.56
ONDS
-3.70%
$10.41
AAPL
+0.04%
$247.77
SRM
+53.27%
$10.30
ATXS
+37.07%
$11.61
HPE
+0.80%
$25.00
IONQ
-5.53%
$77.55
AQMS
+198.89%
$29.62
EOSE
-0.41%
$16.98
NAKA
-7.78%
$0.78
KDLY
-7.78%
$0.78
VALE
-0.36%
$10.97
C
+3.89%
$99.84
RGTZ
-5.37%
$8.80
GRAB
-0.33%
$5.91
HOOD
-4.07%
$134.94
BULL
-0.08%
$11.73
WMT
+4.98%
$107.21
GWH
-16.24%
$7.58
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.